Hologic Announces Financial Results for Second Quarter of Fiscal 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Hologic (HOLX) Tops Q2 EPS by 2c; Guides Q3 Lower
April 28, 2021 4:04 PM EDTHologic (NASDAQ: HOLX) reported Q2 EPS of $2.59, $0.02 better than the analyst estimate of $2.57. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.53 billion.
Hologic posted very strong financial results in our second fiscal quarter in line with our guidance, said... More
